ArticleAdvances in therapy2017

The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies.

Tomohiro Kusawake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.